Literature DB >> 27956447

Towards understanding and managing chronic cough.

Imran Satia1, Huda Badri1, Bashar Al-Sheklly1, Jaclyn Ann Smith1, Ashley A Woodcock2.   

Abstract

Chronic cough is a common and troublesome condition affecting approximately 12% of the general population. It is associated with poor quality of life with psychological, social and physical consequences. Patients typically complain of a dry irritating cough, driven by a strong urge to cough associated with a sensation or irritation located in the throat. Treatment of potential 'causes', ie asthma, gastro-oesophageal reflux disease and rhino-sinusitis, may produce a complete or partial response, but the response of some patients to opiates and alpha-2-delta ligand antagonists (gabapentin and pregabalin) supports the concept that this is primarily a neurological disorder, characterised by hyper-responsiveness of the nerves. Novel and highly effective neuronal treatments are in development and offer hope of better symptom control with fewer side effects within a few years. This review focuses on understanding the mechanism of chronic cough, current management approaches and research that may lead to novel therapies. © Royal College of Physicians 2016. All rights reserved.

Entities:  

Keywords:  Capsaicin; P2X3; chronic cough; cough hypersensitivity syndrome; vagus nerve

Mesh:

Year:  2016        PMID: 27956447      PMCID: PMC6329565          DOI: 10.7861/clinmedicine.16-6-s92

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  8 in total

Review 1.  Cough as an adverse effect on inhalation pharmaceutical products.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Sussan Ghassabian; John D Brannan; Heikki O Koskela; Hak-Kim Chan
Journal:  Br J Pharmacol       Date:  2020-08-07       Impact factor: 8.739

2.  Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line.

Authors:  Rob Lambkin-Williams; Alex Mann; Adrian Shephard
Journal:  SAGE Open Med       Date:  2020-09-24

3.  Change in the symptom profile treated as asthma - two cross-sectional studies twenty years apart.

Authors:  Mihkel Pindus; Hans Orru; Rain Jõgi
Journal:  Respir Res       Date:  2020-02-03

4.  Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging.

Authors:  Imran Satia; Alexandra J Mayhew; Nazmul Sohel; Om Kurmi; Kieran J Killian; Paul M O'Byrne; Parminder Raina
Journal:  ERJ Open Res       Date:  2021-05-04

5.  Management of intractable chronic cough during awake craniotomy: illustrative case.

Authors:  Yena Kang; Robbi A Kupfer; Elizabeth Ford-Baldner; Karen J Kluin; Shawn L Hervey-Jumper; Robert J Morrison
Journal:  J Neurosurg Case Lessons       Date:  2021-12-20

6.  Long-Term Outcomes of Chronic Cough Reduction after Laparoscopic Nissen Fundoplication-A Single-Center Study.

Authors:  Natalia Dowgiałło-Gornowicz; Anna Masiewicz; Justyna Kacperczyk; Paweł Lech; Sławomir Saluk; Karolina Osowiecka; Maciej Michalik
Journal:  Medicina (Kaunas)       Date:  2021-12-28       Impact factor: 2.430

7.  Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study.

Authors:  Alyn Morice; Jaclyn A Smith; Lorcan McGarvey; Surinder S Birring; Sean M Parker; Alice Turner; Thomas Hummel; Isabella Gashaw; Lueder Fels; Stefan Klein; Klaus Francke; Christian Friedrich
Journal:  Eur Respir J       Date:  2021-11-18       Impact factor: 16.671

8.  Chronic cough caused by choledochoduodenal fistula: a case report.

Authors:  Jiaofei Cao; Yue Hu; Shaojun Jin; Fei Chen; Li Li; Huaqiong Huang
Journal:  BMC Pulm Med       Date:  2021-09-10       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.